.webp)
Annovis is a Phase 3 clinical-stage company developing transformative therapies for neurodegenerative disease such as Alzheimer's disease (AD) and Parkinson's disease (PD). Our goal is to develop effective treatments for some of the most challenging neurological conditions by restoring nerve cell function and improving cognitive and motor abilities in patients.
Our Alzheimer’s program is dedicated to creating treatments that restore cognitive functions.
Learn MoreOur Parkinson's program focuses on developing therapies that improve motor function and slow disease progression.
Learn MoreOur research extends beyond Alzheimer's and Parkinson’s, addressing multiple neurodegenerative disorders.
Learn More
.svg)
.svg)
.svg)
.svg)